skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 
Home » UK Shares » AIM Risers and Fallers » AIM round-up: Kinovo, Stanley Gibbons, Synairgen

London’s AIM Index has slipped a little today, but losses have been limited to less than four points with the junior market sitting at 897.09 by the bell.

  • Kinovo +26%
  • Stanley Gibbons +20%
  • Synairgen +17%
  • Actual Experiences -47%
  • Forward Partners -16%

Shares in specialist property services company Kinovo [LON:KINO] found themselves at the top of the board today, up some 26%. However with a 15% spread only a scattering of trades and no news, this £7m minnow does look like the day’s outlier. However the stock did come off a long way off the back of last month’s trading update – this is at least helping recover some of those losses.

Stanley Gibbons [LON:SGI] also had a strong day, reaching the bell some 20% higher. However having traded at all time lows at the end of last week, this just looks like some bargain hunting, with limited trade being reported and again a wide spread being quoted at the close.

A notable mention for Synairgen [LON:SNG] which added 17% on the day. Again there’s no specific news here but the pharma sector in general has been finding some support and gains have been sufficient to propel the stock back to levels not seen since the release of earnings almost a month ago.

Actual Experiences [LON:ACT] was the day’s worst performer, down 47% after it announced a contract cancellation after the bell on Friday night. This came about off the back of a change in the customer’s circumstances and doesn’t reflect Actual’s offering, but management noted that the continuing viability of the business would be dependent on securing more sales. A further announcement will be made in due course.

Forward Partners [LON:FWD] slipped 16% off the back of its trading update and full year results which were released this morning. A weakness in investor confidence is slowing funding rounds for some of its portfolio companies, which is in turn dragging on valuations. The company expects to report a mid to high twenty percentage point decline in its venture portfolio valuation at the half year point.  Full year results are set to be issued by the month end.

Related

This article is not investment advice. Investors should do their own research or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we follow most closely. They represent significant growth stories in our view. Our in-depth reports detail why we like them.

Comments

Subscribe for more stories like this, 8am weekdays - for free!


Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Pepperstone
FP Markets
IG
Spreadex
WisdomTree
ActivTrades
Back To Top